The jury's decision is being appealed, according to an attorney involved in the case. 

“These patients are at ongoing risk for aortic complications, reintervention and death," one researcher said. "What’s particularly alarming is that these risks do not subside over time."

Researchers tracked data from more than 23,000 patients, encountering an 'apparent paradox' along the way. 

The new digital journal expects to start seeking submissions later this year. 

The three-day event is sponsored by the Cardiovascular Research Foundation.

The group says it also still supports wearing masks when indoors and practicing social distancing. 

TTE, researchers wrote, was "as good as abdominal ultrasound" when it came to screening for AAA. 

The new study, published in JAMA Internal Medicine, examined data from 144 different randomized clinical trials.

The risk appears to increase more and more when patients consume a higher daily dose. 

Kaiser maintains it has done nothing wrong and said it plans to "strongly" defend against lawsuits alleging otherwise.